Episurf Medical received Israeli Ministry of Health approval to market Episealer® knee products, and entered into a distribution agreement for the region with AMI Technologies.
Episealer devices treat localized cartilage damage in the knee. At the close of 2017, the company announced the 300th surgery with its Episealer personalized implant, representing a doubling of the number of procedures performed as of mid-4Q16.
Episurf Medical received Israeli Ministry of Health approval to market Episealer® knee products, and entered into a distribution agreement for the region with AMI Technologies.
Episealer devices treat localized cartilage damage in the knee. At the close of 2017, the company announced the 300th surgery with its...
Episurf Medical received Israeli Ministry of Health approval to market Episealer® knee products, and entered into a distribution agreement for the region with AMI Technologies.
Episealer devices treat localized cartilage damage in the knee. At the close of 2017, the company announced the 300th surgery with its Episealer personalized implant, representing a doubling of the number of procedures performed as of mid-4Q16.
Copy to clipboard 
